Blue Goat Cyber, a leader in medical device cybersecurity, has announced its sponsorship of LSI Asia 2025, the premier summit for MedTech innovation in the Asia-Pacific region. Taking place June 10–13 in Singapore, the event gathers global stakeholders focused on scaling safe and compliant medical technologies.
Source: lifesciencemarketresearch.com.
As reported by CBS 4 Indianapolis, the highlight of Blue Goat’s presence will be a panel titled “Invisible Risk: Cybersecurity Mistakes That Stall Market Momentum,” moderated by the company’s CTO, Trevor Slattery.
Cybersecurity can’t be an afterthought for MedTech. This panel will provide practical direction for device innovators who want to scale securely and compliantly.
Trevor Slattery, CTO of Blue Goat Cyber
The session will address the hidden cybersecurity pitfalls that delay product approvals, shake investor confidence, and lead to costly postmarket vulnerabilities. “Cybersecurity can’t be an afterthought for MedTech,” Slattery said. “This panel will provide practical direction for device innovators who want to scale securely and compliantly.” Attendees will gain insight into how early-stage cybersecurity investments can unlock faster regulatory approvals and long-term market trust—especially crucial in the heavily regulated APAC region.
With a track record in FDA and APAC compliance, Blue Goat Cyber offers services including SBOM creation, risk assessments, and penetration testing. The firm supports MedTech developers in integrating security into product design from day one—ensuring not only compliance but also credibility in the eyes of investors, regulators, and patients. Visitors to LSI Asia 2025 can meet with Blue Goat experts to explore strategies for reducing risk and accelerating go-to-market timelines.
